Sign up for our daily briefing

Make your busy days simpler with the Axios AM and PM newsletters. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to the Axios Closer newsletter for insights into the day’s business news and trends and why they matter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios Pro Rata

Dive into the world of dealmakers across VC, PE and M&A with Axios Pro Rata. Delivered daily to your inbox by Dan Primack and Kia Kokalitcheva.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with the Axios Sports newsletter. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with the Axios Des Moines newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with the Axios Tampa Bay newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Nashville news?

Get a daily digest of the most important stories affecting your hometown with the Axios Nashville newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Columbus news?

Get a daily digest of the most important stories affecting your hometown with the Axios Columbus newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Dallas news?

Get a daily digest of the most important stories affecting your hometown with the Axios Dallas newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Austin news?

Get a daily digest of the most important stories affecting your hometown with the Axios Austin newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Atlanta news?

Get a daily digest of the most important stories affecting your hometown with the Axios Atlanta newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Philadelphia news?

Get a daily digest of the most important stories affecting your hometown with the Axios Philadelphia newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Chicago news?

Get a daily digest of the most important stories affecting your hometown with the Axios Chicago newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top DC news?

Get a daily digest of the most important stories affecting your hometown with the Axios DC newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Turkish-backed Syrian rebels gather near the border. Photo: Nazeer Al-Khatib/AFP via Getty Images

The White House is insisting that President Trump did not offer Turkey a “green light” to slaughter U.S.-backed Kurdish forces in northern Syria last night and that the U.S. wouldn't bear responsibility for any Islamic State resurgence in the area.

Why it matters: Confusion and concern followed the sudden announcement last night — after a call between Trump and Turkish President Recep Tayyip Erdoğan — that the U.S. would withdraw from the “immediate area” into which Turkish troops are expected to advance.

  • Turkey fiercely opposes the primarily Kurdish forces that hold the area and helped the U.S. retake swathes of Syria from ISIS, leading to bipartisan accusations that Trump is abandoning an ally.
  • The backlash included Sens. Lindsey Graham, Marco Rubio, Mitch McConnell, House Minority Leader Kevin McCarthy and former UN Ambassador Nikki Haley.
  • There was an information vacuum for much of the day beyond the tweets in which Trump reiterated his desire to leave Syria, claimed the Kurds had been "paid massive amounts" to fight ISIS and warned he would "destroy and obliterate" Turkey's economy if it did anything he found "off limits."
Expand chart
Data: Conflict Monitor by IHS Markit as of Oct. 7; Map: Lazaro Gamio/Axios

The latest: A senior administration official told reporters on a call tonight that Trump was withdrawing 50–100 special forces troops currently operating near the Turkey-Syria border, but not pulling out of Syria entirely.

  • The official said Trump had determined Erdoğan was “set on undertaking an operation in northern Syria” after months of threats and said Trump didn’t want U.S. troops in the path of a NATO ally.
  • The official said repeatedly that Trump was not endorsing Erdoğan’s plan, but wouldn’t say whether he’d warned him not to move ahead. 

Kurdish forces are guarding camps that hold thousands of suspected ISIS fighters and have warned they may have to abandon them to counter Turkey.

  • The White House says Turkey would then be "responsible for maintaining the captivity of those fighters" and would bear "full responsibility" if ISIS rebounds in the area.

Between the lines: Jennifer Cafarella of the Institute for the Study of War tells Axios that whether this "spirals into a broader regional war" depends on how the Kurds react to what will likely be a "limited" initial Turkish incursion. The most serious risks for them extend beyond war to potential ethnic cleansing.

The big picture: The senior U.S. official said this was “not the beginning of a formal pullout of Syria,” but added that both Trump and the American people “want our troops home as soon as possible.”

  • “The president has been transparent in his desire to get out of the region, which immediately changes everybody's calculus," Cafarella says. "Most of our adversaries are currently running down the clock expecting that at some point we will leave.”
  • Trump, for his part, says that was always the plan. He tweeted that the U.S. would only fight "WHERE IT IS TO OUR BENEFIT" and that if ISIS returns, "we can always go back & BLAST!"

Go deeper: Top Kurdish commander says Trump's Syria move puts victories over ISIS at risk

Go deeper

Updated 3 hours ago - Politics & Policy

Omicron dashboard

Illustration: Shoshana Gordon/Axios

  1. Health: Axios-Ipsos poll: Omicron's big numbersAnother wave of death — FDA limits use of Regeneron and Lilly antibody treatments — Fauci: "Confident" Omicron cases will peak in February.
  2. Vaccines: Pfizer begins clinical trial for Omicron-specific vaccine — The shifting definition of fully vaccinated.
  3. Politics: Biden admin withdraws temporary vaccine-or-test mandate for large employers — New York Supreme Court strikes down Gov. Hochul's mask mandate for public areas — Sarah Palin tests positive, delaying defamation trial — Virginia school boards sue Gov. Youngkin for lifting mask mandate.
  4. World: U.K. to lift travel testing requirement for fully vaccinated — Beijing Olympic Committee lowers testing threshold ahead of Games.
  5. Variant tracker

The Robinhood M&A rumor mill churns

Illustration: Sarah Grillo/Axios

Robinhood's valuation is now just over $11 billion, a fraction of where it traded in August and below that of its last private round of funding. Cue the M&A mongers.

Why it matters: It's not just Robinhood—falling values of growth-oriented tech stocks have raised speculation that formerly high-flying fintechs could be snapped up by more well-capitalized buyers.

4 hours ago - Health

Student's death renews calls for schools to stock opioid overdose drug

Photo: Amy Davis/Baltimore Sun/Tribune News Service via Getty Images

A Connecticut student's death has renewed calls for schools to stock and administer naloxone, a drug that can quickly reverse the effects of an opioid overdose.

Why it matters: U.S. drug overdose fatalities reached six figures in a 12-month period for the first time in November, and synthetic or natural opioids were the cause of a majority of the overdoses.